Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7343073

COc1cc(OCC(N)=O)c2cc(/C=N\N)ccc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.43
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 3/20 0.36
ASIC1 P78348 1/20 0.35
PLAU P00749 1/20 0.35
AKR1B1 P15121 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
FFAR1 O14842 1/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7343090 1.00 SNCA (0.43) SNCAKMT2AMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL7345802 0.83 PLAU (0.55) SNCAKMT2AMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL7345787 0.83 PLAU (0.55) SNCAKMT2AMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL7343080 0.81 PLAU (0.57) SNCAPLAU
Trifluoroacetic Acid SCHEMBL7337424 0.76 PLAU (0.46) SNCAKMT2AMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL7336995 0.76 PLAU (0.46) SNCAKMT2AMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL7344754 0.72 KDM4E (0.41) KMT2AMEN1ALDH1A1MAPTGAA
Trifluoroacetic Acid SCHEMBL7334981 0.72 PLAU (0.41) SNCAALDH1A1MAPTKDM4EPOLB
Trifluoroacetic Acid SCHEMBL7344763 0.72 KDM4E (0.41) KMT2AMEN1ALDH1A1MAPTGAA
Trifluoroacetic Acid SCHEMBL7334991 0.72 PLAU (0.41) SNCAALDH1A1MAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US claimed
EP-1000018-A2 UROKINASE INHIBITORS Abbott Laboratories (US) 2000-05-17 EP claimed
WO-1999005096-A2 UROKINASE INHIBITORS ABBOTT LABORATORIES (US) 1999-02-04 WO claimed
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 SNCA 4873/4885KMT2A 4585/4885MEN1 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.